Chronic Cough Clinical Trials

87 clinical trials for Chronic Cough across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough — RECRUITING · PHASE2
• Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation — RECRUITING
• Efficacy of Intramuscular Steroid Injection for Chronic Cough. — RECRUITING · PHASE1
• Remodelling of the Lower Airways in Chronic Cough — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF NALBUPHINE EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF PARTICIPANTS WITH REFRACTORY CHRONIC COUGH — RECRUITING
• Finnish Children´s Protracted Cough — RECRUITING · PHASE3
• Efficacy of Behavioral Therapy for Chronic Refractory Cough — RECRUITING · NA
• Canadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough — RECRUITING
• The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges — RECRUITING · PHASE1
• An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough — RECRUITING
• Investigating the Role of ATP Production by Airway Epithelium in Patients With Refractory and Unexplained Chronic Cough (RCC/UCC). — RECRUITING
• A PHASE 3, 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLELARM EFFICACY AND SAFETY STUDY WITH OPEN-LABEL EXTENSION OF BLU-5937 IN ADULT PARTICIPANTS WITH REFRACTORY CHRONIC COUGH INCLUDING UNEXPLAINED CHRONIC COUGH (CALM-2) — RECRUITING · PHASE3
• Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients — RECRUITING
• The Real-world Treatment Satisfaction by Gefapixiant in RCC — RECRUITING · NA
• Impact of Chronic Cough on Activities of Daily Living and Response to Acute High-intensity Exercise — RECRUITING
• A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF TAPLUCAINIUM INHALATION POWDER (NOC-110) IN ADULTS WITH REFRACTORY OR UNEXPLAINED CHRONIC COUGH — RECRUITING · PHASE2
• A study to determine the effect of AF-219 on the urge to cough in patients with long-term cough — COMPLETED · PHASE2
• A study to determine the ability of AF-219 to affect the cough reflex in healthy volunteers and in people affected by long-term coughing — COMPLETED · PHASE2
• Double-Blind Randomised Controlled Trial of Lesogaberan in Chronic Cough Patients This means patients will take Lesogaberan and a dummy drug (called placebo) in a random order. During the study neither the study doctor or patient will know whether they are taking Lesogaberan or placebo as the tablets will look identical. — COMPLETED · PHASE2
• The effect of Lidocaine and its Delivery in Patients with Chronic Cough — COMPLETED · PHASE4
• A 12 week study to assess the efficacy and safety of AF-219 in patients with long term cough — COMPLETED · PHASE2
• Chronic Cough and Small Fiber Neuropathy — TERMINATED · NA
• Feasibility, Acceptability, and Safety Trial of Brief, Breath Control-Focused Acceptance and Commitment Therapy in Adults With Chronic Cough — NOT_YET_RECRUITING · NA
• Comprehensive Analysis of the Swallowing Mechanism Using High-resolution Manometry With Impedance — NOT_YET_RECRUITING · NA
• Study to Investigate the Efficacy and Safety of SC0023, in Adults With Refractory or Unexplained Chronic Cough — COMPLETED · NA
• Wenjuanxing-Based Multidimensional Etiologic Screening and Clinical Validation of Chronic Cough in Children — NOT_YET_RECRUITING
• A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough — NOT_YET_RECRUITING · PHASE4
• A 2X2 FACTORIAL, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE NEUROMODULATORS AND COUGH CONTROL THERAPY IN PATIENTS WITH REFRACTORY OR UNEXPLAINED CHRONIC COUGH: THE FORTITUDE TRIAL — NOT_YET_RECRUITING
• A Prospective, Randomized, Double-blind Study on the Effects of Different Anesthesia Strategies on Postoperative Cough in Patients Undergoing Video-assisted Thoracoscopic Surgery. — NOT_YET_RECRUITING · NA
• Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases — COMPLETED · PHASE4
• A Study of Efficacy and Safety of AX-8 in Chronic Cough — COMPLETED · PHASE2
• UNDERSTANDING THE ROLE OF AIRWAY MUCUS OCCLUSIONS IN CANADIANS WITH ASTHMA, COPD AND CHRONIC COUGH (CANMUC) — NOT_YET_RECRUITING
• Validation Study With a Non-CE Marked Medical Device (MD) — COMPLETED · NA
• Prospective Study on the Evaluation, Patient Reported Outcomes and Effectiveness of Treatment for Chronic Cough — COMPLETED
• Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) — ACTIVE_NOT_RECRUITING · PHASE2
• China Chronic Cough Registry: a Multicenter, Prospective, Observational Study — NOT_YET_RECRUITING
• A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough — COMPLETED · PHASE2
• Chronic COUGH Management in Interstitial Lung DisEase — NOT_YET_RECRUITING · NA
• Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042) — COMPLETED · PHASE3
• Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA — OTHER
• Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough — OTHER · PHASE1
• Single-center Clinical Study on the Safety and Effect of Bronchoscopic Cryotherapy in Patients With Chronic Cough — OTHER · NA
• Evaluation of the effect of CHF6795 on the pharmacokinetics of midazolam, repaglinide and rosuvastatin in healthy subjects — OTHER · PHASE1
• Evaluation of S-600918 in Adults With Refractory Chronic Cough — COMPLETED · PHASE2
• Study for the Development and Validation of Chronic Cough Patient Perspective Questionnaire — COMPLETED
• Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough — OTHER · NA
• A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension — COMPLETED · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL, 4-ARM DOSE RANGING STUDY OF THE SAFETY AND EFFICACY OF NAL ER TABLETS FOR THE TREATMENT OF COUGH IN IDIOPATHIC PULMONARY FIBROSIS (IPF) — COMPLETED
• A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, TWO-PERIOD CROSSOVER EFFICACY AND SAFETY STUDY OF NALBUPHINE ER TABLETS FOR THE TREATMENT OF REFRACTORY CHRONIC COUGH — COMPLETED · PHASE2
• Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043) — COMPLETED · PHASE3

Refine this search